Cardinal Health (NYSE:CAH) Given New $245.00 Price Target at Wells Fargo & Company

Cardinal Health (NYSE:CAH) had its price objective cut by Wells Fargo & Company from $256.00 to $245.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the stock.

Other equities research analysts have also issued research reports about the company. UBS Group set a $260.00 price objective on Cardinal Health and gave the company a “buy” rating in a research note on Friday, February 6th. Barclays upped their target price on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. Robert W. Baird set a $252.00 price target on shares of Cardinal Health in a research report on Friday, February 6th. JPMorgan Chase & Co. lifted their price target on shares of Cardinal Health from $209.00 to $243.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 10th. Finally, Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, April 12th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $243.67.

Cardinal Health Price Performance

CAH traded up $2.25 during trading hours on Friday, reaching $195.13. 2,091,687 shares of the stock traded hands, compared to its average volume of 1,582,999. Cardinal Health has a fifty-two week low of $137.75 and a fifty-two week high of $233.60. The company has a market cap of $45.92 billion, a price-to-earnings ratio of 28.08, a PEG ratio of 1.19 and a beta of 0.53. The firm’s fifty day simple moving average is $213.73 and its two-hundred day simple moving average is $205.46.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the prior year, the company posted $2.35 EPS. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts predict that Cardinal Health will post 10.79 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were paid a dividend of $0.5107 per share. The ex-dividend date was Wednesday, April 1st. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is 29.35%.

Hedge Funds Weigh In On Cardinal Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Global Assets Advisory LLC raised its position in shares of Cardinal Health by 10.8% during the 1st quarter. Global Assets Advisory LLC now owns 1,741 shares of the company’s stock worth $368,000 after purchasing an additional 170 shares during the period. Diversify Wealth Management LLC lifted its stake in Cardinal Health by 126.5% in the first quarter. Diversify Wealth Management LLC now owns 2,711 shares of the company’s stock valued at $550,000 after buying an additional 1,514 shares during the last quarter. Valmark Advisers Inc. lifted its stake in Cardinal Health by 25.3% in the first quarter. Valmark Advisers Inc. now owns 2,112 shares of the company’s stock valued at $446,000 after buying an additional 427 shares during the last quarter. Pittenger & Anderson Inc. boosted its holdings in shares of Cardinal Health by 10.3% during the first quarter. Pittenger & Anderson Inc. now owns 3,490 shares of the company’s stock valued at $737,000 after acquiring an additional 325 shares during the period. Finally, Carnegie Investment Counsel grew its position in shares of Cardinal Health by 12.3% during the first quarter. Carnegie Investment Counsel now owns 1,389 shares of the company’s stock worth $294,000 after acquiring an additional 152 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non?GAAP earnings beat estimates and company raised FY?2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder?friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an “overweight” rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short?term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre?tax goodwill impairment in the Navista & ION reporting unit — a one?time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the “mixed” nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.